Working towards a sustainable future
Advanced biomanufacturing at the AIBN
At the AIBN, we are world renowned in synthetic biology which is the process of developing new materials, fuels, foods, chemicals and medicines from biological materials, or creating them from waste using biological processes.
By changing production practices from those dependent on fossil fuels to biomanufacturing, we are changing the game for our planet.
We map the processes of biology at the nanoscale, in the gene, genome and protein level of organisms so we can harness cells to create and manufacture new sustainable solutions.
Our game changing solutions in advanced biomanufacturing include:
Stay up to date with the latest advanced biomanufacturing news
Stay on top of our industry news and developments, events and opportunities, by joining The Network
Advanced biomanufacturing case studies
Latest advanced biomanufacturing news
The latest news from AIBN on advanced biomanufacturing. 
Read more news
Advanced biomanufacturing research leaders
AIBN researchers are mapping the processes of biology at the nanoscale, in the gene, genome and protein level of organisms so we can harness cells to create and manufacture new sustainable solutions.
 Converting waste, such as plastics, into useful chemicals and products.
 Converting waste, such as plastics, into useful chemicals and products.  Creating future foods.
 Creating future foods.  Reprogramming bacteria to ‘eat’ harmful greenhouse gas waste and produce new chemicals.
Reprogramming bacteria to ‘eat’ harmful greenhouse gas waste and produce new chemicals.  Using cutting-edge gene technology to chart a new path in the field of mRNA vaccines.
 Using cutting-edge gene technology to chart a new path in the field of mRNA vaccines.  Exploring greener fuels.
Exploring greener fuels.  Enabling ecologically sustainable agriculture.
Enabling ecologically sustainable agriculture.  Enabling an established pipeline for the translation of biotherapeutics.
Enabling an established pipeline for the translation of biotherapeutics.  
        







